Literature DB >> 3954416

C reactive protein in the evaluation of febrile illness.

A Putto, O Ruuskanen, O Meurman, H Ekblad, H Korvenranta, J Mertsola, H Peltola, H Sarkkinen, M K Viljanen, P Halonen.   

Abstract

We studied prospectively 154 febrile children to determine the diagnostic value of the quantitative serum C reactive protein concentrations (CRP). Children with acute otitis media, acute tonsillitis, or treated with antibiotics during the two previous weeks and infants less than 2 months of age were excluded. Ninety seven children were from private paediatric practice and 57 were patients who had been admitted to hospital. The comparison group consisted of 75 children with confirmed bacterial infections whose CRP values were recorded retrospectively. In the study group 35 (23%) children had a confirmed viral infection, 92 (59%) had a probable viral infection as judged from the clinical picture and outcome of the illness, and 27 (18%) had a bacterial or probable bacterial infection. When the duration of the disease was more than 12 hours and the CRP value less than 20 mg/l, all children had a confirmed or probable viral infection. Nine children (one from the study group and eight from the comparison group) were found to have a septic infection and a CRP value of 20 mg/l or less. In all these cases, however, the duration of the symptoms was less than 12 hours. In addition CRP less than or equal to 20 mg/l was found in five (14%) children with urinary tract infection in the comparison group. CRP values of 20-40 mg/l were recorded in children with both viral and bacterial infections. A CRP value greater than or equal to 40 mg/l detected 79% of bacterial infections with 90% specificity. Our data show that determination of serum CRP concentrations is a valuable tool in evaluating children who have been ill for more than 12 hours.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954416      PMCID: PMC1777528          DOI: 10.1136/adc.61.1.24

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  C-reactive protein in respiratory virus infections.

Authors:  O Ruuskanen; A Putto; H Sarkkinen; O Meurman; K Irjala
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

2.  Level diagnosis of symptomatic urinary tract infections in childhood.

Authors:  U Jodal; U Lindberg; K Lincoln
Journal:  Acta Paediatr Scand       Date:  1975-03

3.  C-reactive protein and zeta sedimentation ratio as indicators of bacteremia in pediatric patients.

Authors:  M Bennish; M O Beem; V Ormiste
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

4.  Comparison of acute-phase reactants in pediatric patients with fever.

Authors:  P L McCarthy; J F Jekel; T F Dolan
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

5.  Rapid diagnosis of adenoviral tonsillitis: a prospective clinical study.

Authors:  O Ruuskanen; H Sarkkinen; O Meurman; P Hurme; T Rossi; P Halonen; P Hänninen
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

6.  Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction.

Authors:  I Kushner; M L Broder; D Karp
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Detection of respiratory syncytial, parainfluenza type 2, and adenovirus antigens by radioimmunoassay and enzyme immunoassay on nasopharyngeal specimens from children with acute respiratory disease.

Authors:  H K Sarkkinen; P E Halonen; P P Arstila; A A Salmi
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

8.  C-reactive protein as a detector of organic complications during recovery from childhood purulent meningitis.

Authors:  H Peltola; K Luhtala; P Valmari
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

9.  C-reactive protein in patients with bacteremia.

Authors:  R E McCabe; J S Remington
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

10.  Temperature greater than or equal to 40 C in children less than 24 months of age: a prospective study.

Authors:  P L McCarthy; J F Jekel; T F Dolan
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

View more
  23 in total

1.  A wake up call for primary care.

Authors:  Allyson Pollock
Journal:  Br J Gen Pract       Date:  2002-11       Impact factor: 5.386

2.  Community pneumonia--more help is needed to diagnose and assess severity.

Authors:  Hasse Melbye
Journal:  Br J Gen Pract       Date:  2002-11       Impact factor: 5.386

Review 3.  How useful is C-reactive protein in detecting occult bacterial infection in young children with fever without apparent focus?

Authors:  Nitin Maheshwari
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

4.  Fever in medical service patients.

Authors:  B A Lipsky
Journal:  J Gen Intern Med       Date:  1988 Mar-Apr       Impact factor: 5.128

5.  Acute phase response in cerebral infarction.

Authors:  J Syrjänen; A M Teppo; V V Valtonen; M Iivanainen; C P Maury
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

6.  C-reactive protein in the management of children with fever after allogeneic bone marrow transplantation.

Authors:  C de Bel; E Gerritsen; G de Maaker; A Moolenaar; J Vossen
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

7.  C reactive protein concentrations in cystic fibrosis.

Authors:  R E Moreton; C R Kennedy
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

Review 8.  Tests for detecting and monitoring the acute phase response.

Authors:  J Stuart; J T Whicher
Journal:  Arch Dis Child       Date:  1988-02       Impact factor: 3.791

9.  Concentrations of IL-15, IL-18, IFN-γ and activity of CD4+, CD8+ and NK cells at admission in children with viral bronchiolitis.

Authors:  Elżbieta Grześk; Sylwia Kołtan; Robert Dębski; Mariusz Wysocki; Marzena Gruszka; Małgorzata Kubicka; Andrzej Kołtan; Grzegorz Grześk; Sławomir Manysiak; Grażyna Odrowąż-Sypniewska
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

10.  Recurrent wheezy bronchitis and viral respiratory infections.

Authors:  J Mertsola; T Ziegler; O Ruuskanen; T Vanto; A Koivikko; P Halonen
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.